Related Experiment Video
Updated: Apr 7, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options
Shirley C Wang1, Sheila C Wang, Afsaneh Alavi
1Shirley C. Wang, MD • Clinical Research Coordinator • University Health Network • Toronto, Ontario, Canada Sheila C. Wang, PhD • Resident • Department of Dermatology, McGill University • Montreal, Quebec, Canada Afsaneh Alavi, MD, MSc, FRCPC • Assistant Professor • Department of Medicine (Dermatology), University of Toronto • Ontario, Canada Raed Alhusayen, MD, MSc (Clin Epi), FRCPC • Assistant Professor • Sunnybrook Health Sciences Centre • University of Toronto • Ontario, Canada Morteza Bashash, PhD • Research Fellow • Dalla Lana Faculty of Public Health • University of Toronto, Ontario, Canada R. Gary Sibbald, BSc, MD, MEd, FRCPC (Med Derm), MACP, FAAD, MAPWCA • Professor of Public Health and Medicine • University of Toronto • Toronto, Ontario, Canada • Director • International Interprofessional Wound Care Course & Masters of Science in Community Health (Prevention & Wound Care) • Dalla Lana School of Public Health • University of Toronto • Past President, World Union of Wound Healing Societies • Clinical Editor • Advances in Skin & Wound Care • Philadelphia, Pennsylvania.
Abstract:
Hidradenitis suppurativa (HS) is a chronic inflammatory disorder of the intertriginous area. Patients with HS have several challenges to their quality of life and activities of everyday living, including malodor, purulent discharge, and discomfort. There is often a delay in diagnosis and appropriate treatment. The need for cosmetically acceptable local treatments and dressing application makes this disease an important challenge for wound care specialists. The choice of optimal treatment varies depending on the disease severity, expert knowledge, the availability of an interprofessional team, and patient factors.
Related Concept Videos
Acne Infection
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peripheral Artery Disease III: Interprofessional Care
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Aneurysm III: Interprofessional Care
